GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heart Test Laboratories Inc (NAS:HSCS) » Definitions » YoY EPS Growth

Heart Test Laboratories (Heart Test Laboratories) YoY EPS Growth : 81.25% (As of Jan. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Heart Test Laboratories YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Heart Test Laboratories's YoY EPS Growth for the quarter that ended in Jan. 2024 was 81.25%.

Heart Test Laboratories's Earnings per Share (Diluted) for the three months ended in Jan. 2024 was $-3.00.


Heart Test Laboratories YoY EPS Growth Historical Data

The historical data trend for Heart Test Laboratories's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heart Test Laboratories YoY EPS Growth Chart

Heart Test Laboratories Annual Data
Trend Apr20 Apr21 Apr22 Apr23
YoY EPS Growth
- 35.66 -95.20 -34.41

Heart Test Laboratories Quarterly Data
Apr20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.90 36.78 53.57 27.27 81.25

Heart Test Laboratories YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Heart Test Laboratories's YoY EPS Growth for the fiscal year that ended in Apr. 2023 is calculated as:

YoY EPS Growth (A: Apr. 2023 )
=(Earnings per Share (Diluted) (A: Apr. 2023 )-Earnings per Share (Diluted) (A: Apr. 2022 ))/ | Earnings per Share (Diluted) (A: Apr. 2022 ) |
=(-80--59.519)/ | -59.519 |
=-34.41 %

Heart Test Laboratories's YoY EPS Growth for the quarter that ended in Jan. 2024 is calculated as:

YoY EPS Growth (Q: Jan. 2024 )
=(Earnings per Share (Diluted) (Q: Jan. 2024 )-Earnings per Share (Diluted) (Q: Jan. 2023 )) / | Earnings per Share (Diluted) (Q: Jan. 2023 )) |
=(-3--16)/ | -16 |
=81.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Heart Test Laboratories YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Heart Test Laboratories's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Heart Test Laboratories (Heart Test Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.
Executives
David R. Wells director 2801 OCEAN PARK BLVD., SUITE 339, SANTA MONICA CA 90405
Bruce Bent director 750 BONHAM PARKWAY, LANTANA TX 76226
Mark T Hilz director, officer: See Remarks 3301 DAKOTA DRIVE, NORTHLAKE TX 76226
Patrick Kanouff director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Brian Szymczak director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Danielle Watson officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Andrew Simpson director, officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092

Heart Test Laboratories (Heart Test Laboratories) Headlines